Showing results (231-240 of 409) with videos related to
Sort By:
Pageof 41
Molecular Genetics and Metabolism|July 6, 2004
Neuropathology provides clues to the pathophysiology of Gaucher diseaseKondi Wong, Ellen Sidransky, Ajay Verma, et al.Journal of the American Society of Nephrology : JASN|April 10, 2009
Agalsidase alfa and kidney dysfunction in Fabry diseaseMichael West, Kathy Nicholls, Atul Mehta, et al.Human Molecular Genetics|February 22, 2015
Blocking hyperactive androgen receptor signaling ameliorates cardiac and renal hypertrophy in Fabry miceJin-Song Shen, Xing-Li Meng, Mary Wight-Carter, et al.Neurogenetics|January 18, 2006
PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1Patricia Combes, Marie-Noelle Bonnet-Dupeyron, Fernande Gauthier-Barichard, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2024
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDSTanuja Chitnis, Brenda Banwell, Ludwig Kappos, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2015
Viral exposures and MS outcome in a prospective cohort of children with acquired demyelinationNaila Makhani, Brenda Banwell, Raymond Tellier, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|January 12, 2023
Plasma neurofilament light chain in children with relapsing MS receiving teriflunomide or placebo: A post hoc analysis of the randomized TERIKIDS trialJens Kuhle, Tanuja Chitnis, Brenda Banwell, et al.Multiple Sclerosis and Related Disorders|April 11, 2024
Assessment of dietary intake and its inflammatory potential in persons with pediatric-onset multiple sclerosisSama Bitarafan, Feng Zhu, Ali Mirza, et al.Neuropediatrics|August 27, 2016
Update on Leukodystrophies: A Historical Perspective and Adapted DefinitionSietske H Kevelam, Marjan E Steenweg, Siddharth Srivastava, et al.Annals of Neurology|December 11, 2008
Randomized, controlled trial of miglustat in Gaucher's disease type 3Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, et al.Pageof 41